|
141
|
366
|
9dhgA |
Dhodh in complex with compound 5 |
|
142
|
368
|
9dhhA |
Dhodh in complex with compound 8 |
|
146
|
368
|
9dhjA |
Dhodh in complex with compound 15 |
|
141
|
366
|
9dhiA |
Dhodh in complex with compound 7 |
|
66
|
188
|
8u1yA |
E.coli dsba in complex with n-(4-(thiophen-3-yl)benzyl)cyclohexanamine |
|
141
|
468
|
9bv6A |
Crystal structure of human cyp3a4 in complex with sj000388260 |
|
153
|
469
|
9bv8A |
Crystal structure of human cyp3a4 in complex with sjyhj-114 |
|
136
|
469
|
9bvbA |
Crystal structure of human cyp3a4 in complex with sjyhj-075 |
|
139
|
470
|
9bvcA |
Crystal structure of human cyp3a4 in complex with sjyhj-110 |
|
140
|
470
|
9bv9A |
Crystal structure of human cyp3a4 in complex with z56791366 |
|
161
|
470
|
9bv5A |
Crystal structure of human cyp3a4 in complex with sj000362065 |
|
148
|
470
|
9bv7A |
Crystal structure of human cyp3a4 in complex with sj000310315 |
|
143
|
470
|
9bvaA |
Crystal structure of human cyp3a4 in complex with sjyhj-106 |
|
128
|
414
|
9q4zA |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-((5-(2-(ethyl(methyl)amino)ethyl)-2,3-difluorophenxy)methyl)-4-methylphridin-2-amine |
|
126
|
413
|
9q4xA |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-((5-(2-(dimethylamino)ethyl)-2,3-difluorophenoxy)methyl)-4-methylpyridin-2-amine |
|
130
|
414
|
9q53A |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-((2,3-difluoro-5-(2-(piperidin-1-yl)ethyl)phenoxy)methyl)-4-methylpyridin-2-amine |
|
119
|
414
|
9q4yA |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-((2,3-difluoro-5-(2-(methylamino)ethyl)phenoxy)methyl)-4-methylpyridin-2-amine |
|
128
|
413
|
9q51A |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-((5-(2-(diethylamino)ethyl)-2,3-difluorophenxy)methyl)-4-methylpyridin-2-amine |
|
126
|
418
|
9q4wA |
Structure of rat neuronal nitric oxide synthase r349a mutant heme domain bound with 6-((5-(2-(4,4-difluoropiperidin-1-yl)ethyl-2,3-difluorophenoxy)methyl)-4-methylpyridin-2-amine |
|
126
|
414
|
9q58A |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-((5-(2-(4,4-difluoropiperidin-1-yl)ethyl-2,3-difluorophenoxy)methyl)-4-methylpyridin-2-amine |
|
122
|
414
|
9q52A |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-((5-(2-(azetidin-1-yl)ethyl)-2,3-difluorophenxy)methyl)-4-methylpyridin-2-amine |
|
122
|
414
|
9q54A |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-((2,3-difluoro-5-(2-(3-fluoroazetidin-1-yl)ethyl)phenoxy)methyl)-4-methylpyridin-2-amine |
|
105
|
255
|
9pflA |
Crystal structure of human 15-pgdh in complex with small molecule compound 1 |
|
137
|
363
|
8vhmA |
Structure of dhodh in complex with fragment 2 |
|
135
|
365
|
8vhlA |
Structure of dhodh in complex with ligand 17 |
|
158
|
464
|
8u0qA |
Co-crystal structure of optimized analog tdi-13537 provided new insights into the potency determinants of the sulfonamide inhibitor series |
|
215
|
671
|
7lafA |
15-lipoxygenase-2 loop mutant bound to imidazole-based inhibitor |
|
103
|
315
|
8fh7A |
Crystal structure of aldose reductase (akr1b1) complexed with nadp+ and at-003 |
|
101
|
315
|
8fh5A |
Crystal structure of aldose reductase (akr1b1) complexed with nadp+ and at-001 |
|
104
|
315
|
8fh6A |
Crystal structure of aldose reductase (akr1b1) complexed with nadp+ and two at-001 |
|
107
|
310
|
7l00A |
Crystal structure of c. difficile enoyl-acyl carrier protein reductase (fabk) in complex with an inhibitor |
|
131
|
335
|
7t6hA |
E. coli dihydroorotate dehydrogenase |
|
128
|
335
|
7t5kA |
E. coli dihydroorotate dehydrogenase bound to the inhibitor hqno |
|
125
|
336
|
7t5yA |
E. coli dihydroorotate dehydrogenase bound to the inhibitor hmnq |
|
128
|
335
|
7t6cA |
E. coli dihydroorotate dehydrogenase bound to the ubiquinone surrogate dcip |
|
162
|
462
|
7n3lA |
Co-complex cyp46a1 with 0420 (compound 6) |
|
106
|
357
|
7jm5A |
Crystal structure of kdm4b in complex with qc6352 |
|
39
|
166
|
5scrA |
Crystal structure of dihydrofolate reductase from mycobacterium tuberculosis bound to nadp and sddc inhibitor sddc-735 |
|
41
|
166
|
5scuA |
Crystal structure of dihydrofolate reductase from mycobacterium tuberculosis bound to nadp and sddc inhibitor sddc-888 |
|
43
|
173
|
5sctA |
Crystal structure of dihydrofolate reductase from mycobacterium tuberculosis bound to nadp and sddc inhibitor sddc-783 |
|
42
|
167
|
5scsA |
Crystal structure of dihydrofolate reductase from mycobacterium tuberculosis bound to nadp and sddc inhibitor sddc-781 |
|
42
|
166
|
5scqA |
Crystal structure of dihydrofolate reductase from mycobacterium tuberculosis bound to nadp and sddc inhibitor sddc-614 |
|
39
|
166
|
5sd3A |
Crystal structure of dihydrofolate reductase from mycobacterium tuberculosis bound to nadp and sddc inhibitor sddc-1088 |
|
45
|
166
|
5sczA |
Crystal structure of dihydrofolate reductase from mycobacterium tuberculosis bound to nadp and sddc inhibitor sddc-1224 |
|
52
|
186
|
5sd9A |
Crystal structure of dihydrofolate reductase from homo sapiens bound to nadp and sddc inhibitor sddc-1096 |
|
41
|
166
|
5sd5A |
Crystal structure of dihydrofolate reductase from mycobacterium tuberculosis bound to nadp and sddc inhibitor sddc-1230 |
|
44
|
166
|
5sd4A |
Crystal structure of dihydrofolate reductase from mycobacterium tuberculosis bound to nadp and sddc inhibitor sddc-1218 |
|
43
|
166
|
5scoA |
Crystal structure of dihydrofolate reductase from mycobacterium tuberculosis bound to nadp and sddc inhibitor sddc-m7 |
|
54
|
187
|
5sd6A |
Crystal structure of dihydrofolate reductase from homo sapiens bound to nadp and sddc inhibitor sddc-892 |
|
44
|
168
|
5scpA |
Crystal structure of dihydrofolate reductase from mycobacterium tuberculosis bound to nadp and sddc inhibitor sddc-23 |
